The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy

Cancer immunotherapy shows durable treatment responses and therapeutic benefits compared to other cancer treatment modalities, but many cancer patients display primary and acquired resistance to immunotherapeutics. Immunosuppressive tumor microenvironment (TME) is a major barrier to cancer immunothe...

Full description

Bibliographic Details
Main Authors: Zakia Akter, Narges Salamat, Md. Yousuf Ali, Li Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1072739/full
_version_ 1797960344842272768
author Zakia Akter
Narges Salamat
Md. Yousuf Ali
Li Zhang
author_facet Zakia Akter
Narges Salamat
Md. Yousuf Ali
Li Zhang
author_sort Zakia Akter
collection DOAJ
description Cancer immunotherapy shows durable treatment responses and therapeutic benefits compared to other cancer treatment modalities, but many cancer patients display primary and acquired resistance to immunotherapeutics. Immunosuppressive tumor microenvironment (TME) is a major barrier to cancer immunotherapy. Notably, cancer cells depend on high mitochondrial bioenergetics accompanied with the supply of heme for their growth, proliferation, progression, and metastasis. This excessive mitochondrial respiration increases tumor cells oxygen consumption, which triggers hypoxia and irregular blood vessels formation in various regions of TME, resulting in an immunosuppressive TME, evasion of anti-tumor immunity, and resistance to immunotherapeutic agents. In this review, we discuss the role of heme, heme catabolism, and mitochondrial respiration on mediating immunosuppressive TME by promoting hypoxia, angiogenesis, and leaky tumor vasculature. Moreover, we discuss the therapeutic prospects of targeting heme and mitochondrial respiration in alleviating tumor hypoxia, normalizing tumor vasculature, and TME to restore anti-tumor immunity and resensitize cancer cells to immunotherapy.
first_indexed 2024-04-11T00:44:34Z
format Article
id doaj.art-49143242d61c45bbaf252a8da6c93b51
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-11T00:44:34Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-49143242d61c45bbaf252a8da6c93b512023-01-05T20:02:06ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-01-011210.3389/fonc.2022.10727391072739The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapyZakia AkterNarges SalamatMd. Yousuf AliLi ZhangCancer immunotherapy shows durable treatment responses and therapeutic benefits compared to other cancer treatment modalities, but many cancer patients display primary and acquired resistance to immunotherapeutics. Immunosuppressive tumor microenvironment (TME) is a major barrier to cancer immunotherapy. Notably, cancer cells depend on high mitochondrial bioenergetics accompanied with the supply of heme for their growth, proliferation, progression, and metastasis. This excessive mitochondrial respiration increases tumor cells oxygen consumption, which triggers hypoxia and irregular blood vessels formation in various regions of TME, resulting in an immunosuppressive TME, evasion of anti-tumor immunity, and resistance to immunotherapeutic agents. In this review, we discuss the role of heme, heme catabolism, and mitochondrial respiration on mediating immunosuppressive TME by promoting hypoxia, angiogenesis, and leaky tumor vasculature. Moreover, we discuss the therapeutic prospects of targeting heme and mitochondrial respiration in alleviating tumor hypoxia, normalizing tumor vasculature, and TME to restore anti-tumor immunity and resensitize cancer cells to immunotherapy.https://www.frontiersin.org/articles/10.3389/fonc.2022.1072739/fulltumor micoenvironmenthememitochondrial respirationhypoxiaangiogenesiscancer immunotherapy
spellingShingle Zakia Akter
Narges Salamat
Md. Yousuf Ali
Li Zhang
The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy
Frontiers in Oncology
tumor micoenvironment
heme
mitochondrial respiration
hypoxia
angiogenesis
cancer immunotherapy
title The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy
title_full The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy
title_fullStr The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy
title_full_unstemmed The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy
title_short The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy
title_sort promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy
topic tumor micoenvironment
heme
mitochondrial respiration
hypoxia
angiogenesis
cancer immunotherapy
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1072739/full
work_keys_str_mv AT zakiaakter thepromiseoftargetinghemeandmitochondrialrespirationinnormalizingtumormicroenvironmentandpotentiatingimmunotherapy
AT nargessalamat thepromiseoftargetinghemeandmitochondrialrespirationinnormalizingtumormicroenvironmentandpotentiatingimmunotherapy
AT mdyousufali thepromiseoftargetinghemeandmitochondrialrespirationinnormalizingtumormicroenvironmentandpotentiatingimmunotherapy
AT lizhang thepromiseoftargetinghemeandmitochondrialrespirationinnormalizingtumormicroenvironmentandpotentiatingimmunotherapy
AT zakiaakter promiseoftargetinghemeandmitochondrialrespirationinnormalizingtumormicroenvironmentandpotentiatingimmunotherapy
AT nargessalamat promiseoftargetinghemeandmitochondrialrespirationinnormalizingtumormicroenvironmentandpotentiatingimmunotherapy
AT mdyousufali promiseoftargetinghemeandmitochondrialrespirationinnormalizingtumormicroenvironmentandpotentiatingimmunotherapy
AT lizhang promiseoftargetinghemeandmitochondrialrespirationinnormalizingtumormicroenvironmentandpotentiatingimmunotherapy